Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
Policy & Regulation
Trends & Finance
Trends and Finance: Page 3
Qiagen, Helix collaborate to market companion diagnostic products for hereditary diseases
Under the agreement, Qiagen will be the exclusive marketing and contracting partner in the U.S. for Helix’s companion diagnostic services.
January 5, 2023
Matrix Medical Network sells laboratory service line to Karrington Clinical Laboratory
The transition of ownership is part of an overall strategy Matrix announced last year to refocus its portfolio of services on in-home health and care assessments.
January 4, 2023
OpGen announces one-for-20 reverse stock split
The reverse stock split, approved by its stockholders at a special meeting on November 30, has been implemented to increase the firm's share price so that it could regain compliance with Nasdaq’s minimum bid price listing requirement.
January 5, 2023
Thermo Fisher Scientific, Heska complete previously announced acquisitions
Thermo Fisher completed its previously-announced acquisition of specialty diagnostics firm The Binding Site Group, while Heska closed the acquisition of point-of-care test developer LightDeck Diagnostics.
January 3, 2023
Alercell preparing January launch of sequencing test for leukemia
The Montana-based firm also aims to launch a methylation-based molecular diagnostic test for lung cancer later in the first quarter of 2023.
December 29, 2022
Defense Logistics Agency awards $410 million to U.S. suppliers for COVID-19 kits
One supplier, ADG, said the award demonstrates a strategic shift toward an American-made and sourced policy, intended to ensure domestic industrial base capability and capacity in areas critical to the US response to any national emergency.
December 28, 2022
Most Popular
Quest Diagnostics Q4 revenues down 15% on COVID testing but base business grew
In pilot study, liquid biopsy test differentiates between localized and metastatic cancer to inform tailored treatment
SD Biosensor, SJL Partners complete acquisition of Meridian Bioscience
Roche reports flat diagnostics revenue growth for 2022
French point-of-care testing firm Biosynex to acquire Chembio Diagnostics for $17.2M
Sherlock Biosciences acquires Sense Biodetection to drive CRISPR-based test adoption
T2 Biosystems nabs contract extension with group purchasing organization
Products covered under the contract with Vizient, a purchasing organization for healthcare institutions, include the T2Dx Instrument, T2Bacteria Panel, and T2Candida Panel. All detect sepsis-causing bacterial and fungal pathogens from whole blood.
December 28, 2022
Minnesota residents to get Cue Health COVID-19 testing, treatment at no cost
Minnesotans who test positive on any COVID-19 self test can consult virtually and on-demand with a healthcare professional to obtain a prescription when deemed necessary for COVID-19 treatment at no cost.
December 23, 2022
HTG Molecular Diagnostics prices $10M public offering
HTG uses transcriptome-wide profiling for translational research, novel therapeutics, and clinical diagnostics across a variety of disease areas.
December 22, 2022
Fujifilm to enter digital pathology space with acquisition of Inspirata digital pathology platform
The acquisition signals Fujifilm's entry into the digital pathology market. At present, 85% of U.S., 86% of European, and 90% of Asian healthcare organizations are still running on analog pathology.
December 19, 2022
Integrated DNA Technologies acquires Invitae’s Archer NGS research assays for $48M
IDT said that the addition of next-generation sequencing research panels and bioinformatics expands IDT's position as an oncology research solutions provider.
December 20, 2022
Georgia lab owner convicted in $463M genetic testing scheme to defraud Medicare
From July 2016 through August 2019, LabSolutions submitted more than $463 million in claims to Medicare, including for medically unnecessary genetic tests.
December 15, 2022
Previous Page
Page 3 of 109
Next Page
